Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Sequana Medical    SEQUA   BE0974340722

SEQUANA MEDICAL

(SEQUA)
  Report
Delayed Quote. Delayed Euronext Bruxelles - 02/21 10:49:03 am
6.92 EUR   --.--%
02/03SEQUANA MEDICAL : Threshold crossings
CO
01/29SEQUANA MEDICAL : Threshold crossings
CO
2019Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
GL
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
02/17/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
7(c) 7(c) 6.94(c) 6.92(c) 6.92(c) Last
11 060 2 552 2 767 2 370 3 303 Volume
-0.85% 0.00% -0.86% -0.29% 0.00% Change
More quotes
Financials (EUR)
Sales 2019 2,00 M
EBIT 2019 -12,1 M
Net income 2019 -12,6 M
Debt 2019 7,90 M
Yield 2019 -
Sales 2020 3,30 M
EBIT 2020 -11,1 M
Net income 2020 -11,6 M
Debt 2020 9,10 M
Yield 2020 -
P/E ratio 2019 -6,92x
P/E ratio 2020 -7,52x
EV / Sales2019 56,3x
EV / Sales2020 34,5x
Capitalization 105 M
More Financials
Company
More about the company
Latest news on SEQUANA MEDICAL
02/03SEQUANA MEDICAL : Threshold crossings
CO
01/29SEQUANA MEDICAL : Threshold crossings
CO
2019Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Up..
GL
2019Sequana Medical Announces First Patient Enrolled in North American alfapump® ..
GL
2019SEQUANA MEDICAL : Nomination
CO
2019SEQUANA MEDICAL : Half-year report
CO
2019Sequana Medical Announces Unconditional IDE Approval from U.S. FDA to Start a..
GL
2019SEQUANA MEDICAL : Announces Presentation of Positive DSR Clinical Proof-of-Conce..
AQ
2019SEQUANA MEDICAL : Announces Presentation of Positive DSR Clinical Proof-of-Conce..
AQ
2019SEQUANA MEDICAL : Ordinary general shareholder meeting
CO
2019SEQUANA MEDICAL : announces 2018 Full Year Results and 2019 Outlook
AQ
2019SEQUANA MEDICAL : Extraordinary general shareholder meeting
CO
2018SEQUANA MEDICAL : Annual Report
CO
More news
News in other languages on SEQUANA MEDICAL
2019AVIS D'ANALYSTES DU JOUR : Dassault Aviation, Vinci, Egide, Aryzta, Sabadell, In..
2019Le papetier Sequana, propriétaire d'Arjowiggins, mis en liquidation judiciair..
2019AVIS D'ANALYSTES DU JOUR : Air France, Bouygues, Elior, Korian, Somfy, Ryanair, ..
More news
Sector news : Biotechnology & Medical Research - NEC
02/20Anglo American Discloses All Mine Deaths in Industry Shift--Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift -- Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift
DJ
02/20GlaxoSmithKline Invests $50 Million in Biotech Startup's Cell-Therapy Program
DJ
02/19Five Prime Therapeutics In License Agreement with Seattle Genetics
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart SEQUANA MEDICAL
Duration : Period :
Sequana Medical Technical Analysis Chart | SEQUA | BE0974340722 | MarketScreener
Technical analysis trends SEQUANA MEDICAL
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 13,10  €
Last Close Price 6,92  €
Spread / Highest target 95,1%
Spread / Average Target 89,3%
Spread / Lowest Target 83,5%
EPS Revisions
Managers
NameTitle
Ian Crosbie Chief Executive Officer & Executive Director
Pierre Hubert Andre Chauvineau Chairman
Kirsten van Bockstaele Chief Financial Officer
Gijs Klarenbeek Chief Medial Officer
Rudy Dekeyser Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SEQUANA MEDICAL10.54%114
LONZA GROUP19.03%31 846
IQVIA HOLDINGS INC.5.77%31 512
SEATTLE GENETICS, INC.2.40%20 154
CELLTRION, INC.--.--%19 564
INCYTE CORPORATION-5.21%17 535